K-Ras(G12C) inhibitor 9
K-Ras(G12C) inhibitor 9 Basic information
- Product Name:
- K-Ras(G12C) inhibitor 9
- Synonyms:
-
- K-Ras(G12C) inhibitor 9
- N-[1-[2-[(4-chloro-5-iodo-2-methoxyphenyl)amino]acetyl]-4-piperidinyl]-ethenesulfonamide
- K RAS INHIBITOR-9; KRAS INHIBITOR 9
- K-RAS inhibitor 9
- Ethenesulfonamide, N-[1-[2-[(4-chloro-5-iodo-2-methoxyphenyl)amino]acetyl]-4-piperidinyl]-
- K-Ras(G12C) inhibitor 9 USP/EP/BP
- K-Ras(G-12C) inhibitor 9,KRas(G12C) inhibitor 9,Ras,Inhibitor,K-Ras(G12C) inhibitor 9,inhibit,K Ras(G12C) inhibitor 9
- K-Ras(GI2C) Inhibitor 9
- CAS:
- 1469337-91-4
- MF:
- C16H21ClIN3O4S
- MW:
- 513.78
- Product Categories:
-
- Inhibitors
- Mol File:
- 1469337-91-4.mol
K-Ras(G12C) inhibitor 9 Chemical Properties
- Boiling point:
- 656.3±65.0 °C(Predicted)
- Density
- 1.68±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- crystalline solid
- pka
- 9.68±0.20(Predicted)
- color
- White to off-white
K-Ras(G12C) inhibitor 9 Usage And Synthesis
Description
K-Ras(G12C) inhibitor 9 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro. K-Ras is a small GTPase that cycles between a GTP-bound active state and a GDP-bound inactive state to turn on downstream Raf kinases to drive cell growth. A G12C mutation in K-Ras blocks GTP hydrolysis, activates K-Ras, and promotes carcinogenesis. Similar K-Ras(G12C) inhibitors significantly reduce GTP affinity relative to GDP, decrease Raf binding, and lower cell viability while increasing apoptosis.
Uses
N-[1-[2-[(4-Chloro-5-iodo-2-methoxyphenyl)amino]acetyl]-4-piperidinyl]ethenesulfonamide is an allosteric inhibitor of tumor-promoting K-Ras(G12c).
in vitro
k-ras(g12c) inhibitor 9 belongs to a series of small molecules, which irreversibly compete with gtp and gdp for binding to a common oncogenic k-ras(g12c) mutant and blocked the association of b-raf and c-raf with k-ras(g12c). k-ras(g12c) inhibitor 9 (10 μm) decreased viability and increased apoptosis of g12c mutations-containing lung cancer cell lines (h1792, calu-1, h358, and h23) [1].
target
k-ras(g12c)
References
1. ostrem jm, peters u, sos ml, wells ja, shokat km. k-ras(g12c) inhibitors allosterically control gtp affinity and effector interactions. nature. 2013;503(7477):548-51. 2. hunter jc, gurbani d, ficarro sb, carrasco ma, lim sm, choi hg, et al. in situ selectivity profiling and crystal structure of sml-8-73-1, an active site inhibitor of oncogenic k-ras g12c. proc natl acad sci u s a. 2014;111(24):8895-900. 3. lim sm, westover kd, ficarro sb, harrison ra, choi hg, pacold me, et al. therapeutic targeting of oncogenic k-ras by a covalent catalytic site inhibitor. angew chem int ed engl. 2014;53(1):199-204.
K-Ras(G12C) inhibitor 9Supplier
- Tel
- +1 (866) 930-6790
- info@adooq.com
- Tel
- 13120367189
- mychess007@163.com
- Tel
- 025-58849295 18951903616;
- info@adooq.cn
- Tel
- +86-21-58447131
- 1724405207@qq.com
- Tel
- 16314854226
- info@bocsci.com
K-Ras(G12C) inhibitor 9(1469337-91-4)Related Product Information
- Creatine Phosphokinase
- 1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- JAK INHIBITOR I
- NADH Inhibitor
- RIBONUCLEASE INHIBITOR
- K-Ras inhibitor
- Bortezomib
- LONAFARNIB
- Neratinib
- K-Ras(G12C) inhibitor 6
- 1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one